JP2020516672A5 - - Google Patents

Download PDF

Info

Publication number
JP2020516672A5
JP2020516672A5 JP2019556274A JP2019556274A JP2020516672A5 JP 2020516672 A5 JP2020516672 A5 JP 2020516672A5 JP 2019556274 A JP2019556274 A JP 2019556274A JP 2019556274 A JP2019556274 A JP 2019556274A JP 2020516672 A5 JP2020516672 A5 JP 2020516672A5
Authority
JP
Japan
Prior art keywords
pyrazole
methyl
oxo
benzonitrile
dihydropyridine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2019556274A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020516672A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2018/028097 external-priority patent/WO2018195155A1/en
Publication of JP2020516672A publication Critical patent/JP2020516672A/ja
Publication of JP2020516672A5 publication Critical patent/JP2020516672A5/ja
Priority to JP2023009579A priority Critical patent/JP2023088901A/ja
Pending legal-status Critical Current

Links

JP2019556274A 2017-04-18 2018-04-18 治療用化合物 Pending JP2020516672A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2023009579A JP2023088901A (ja) 2017-04-18 2023-01-25 治療用化合物

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201762486894P 2017-04-18 2017-04-18
US62/486,894 2017-04-18
US201862657456P 2018-04-13 2018-04-13
US62/657,456 2018-04-13
PCT/US2018/028097 WO2018195155A1 (en) 2017-04-18 2018-04-18 Therapeutic compounds

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023009579A Division JP2023088901A (ja) 2017-04-18 2023-01-25 治療用化合物

Publications (2)

Publication Number Publication Date
JP2020516672A JP2020516672A (ja) 2020-06-11
JP2020516672A5 true JP2020516672A5 (https=) 2021-04-30

Family

ID=63791349

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2019556274A Pending JP2020516672A (ja) 2017-04-18 2018-04-18 治療用化合物
JP2023009579A Pending JP2023088901A (ja) 2017-04-18 2023-01-25 治療用化合物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2023009579A Pending JP2023088901A (ja) 2017-04-18 2023-01-25 治療用化合物

Country Status (5)

Country Link
US (4) US10617680B2 (https=)
EP (1) EP3612522A4 (https=)
JP (2) JP2020516672A (https=)
TW (2) TWI788343B (https=)
WO (1) WO2018195155A1 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018195155A1 (en) * 2017-04-18 2018-10-25 Celgene Quanticel Research, Inc. Therapeutic compounds
US10870648B2 (en) * 2018-06-29 2020-12-22 Forma Therapeutics, Inc. Inhibiting CREB binding protein (CBP)
GB201905721D0 (en) 2019-04-24 2019-06-05 Univ Dundee Compounds
TW202304303A (zh) * 2021-04-13 2023-02-01 美商富曼西公司 殺真菌之吡啶酮
CA3224302A1 (en) 2021-06-29 2023-01-05 Tay Therapeutics Limited Pyrrolopyridone derivatives useful in the treatment of cancer
WO2025010291A2 (en) * 2023-07-03 2025-01-09 The General Hospital Corporation Targeted epigenetic therapies for disorders of progranulin deficiency

Family Cites Families (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3406329A1 (de) * 1984-02-22 1985-08-22 Merck Patent Gmbh, 6100 Darmstadt Pyridone
CA2221692A1 (en) 1995-05-19 1996-11-21 G.D. Searle & Co. Substituted oxazoles for the treatment of inflammation
JPH11508267A (ja) * 1995-06-26 1999-07-21 藤沢薬品工業株式会社 ピラゾール化合物および医薬組成物
JP3760957B2 (ja) * 1996-03-05 2006-03-29 信越化学工業株式会社 新規スルホニウム塩及び化学増幅ポジ型レジスト材料
US6841549B1 (en) * 1999-07-02 2005-01-11 Eisai Co., Ltd. Condensed imidazole compounds and a therapeutic agent for diabetes mellitus
AU2002306868A1 (en) * 2001-03-28 2002-10-15 Pharmacia Corporation Therapeutic combinations for cardiovascular and inflammatory indications
EP1660087A2 (en) 2003-07-22 2006-05-31 Janssen Pharmaceutica N.V. Quinolinone derivatives as inhibitors of c-fms kinase
WO2005013982A1 (en) * 2003-08-06 2005-02-17 Vertex Pharmaceuticals Incorporated Aminotriazole compounds useful as inhibitors of protein kinases
WO2005095384A1 (en) * 2004-04-01 2005-10-13 Astellas Pharma Inc. Pyrazine derivatives and pharmaceutical use thereof as adenosine antagonists
EP1604988A1 (en) * 2004-05-18 2005-12-14 Sanofi-Aventis Deutschland GmbH Pyridazinone derivatives, methods for producing them and their use as pharmaceuticals
GB0420722D0 (en) * 2004-09-17 2004-10-20 Addex Pharmaceuticals Sa Novel allosteric modulators
US7361654B2 (en) 2005-01-13 2008-04-22 Bristol-Myers Squibb Co. Substituted heteroaryl amide modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof
JPWO2006137465A1 (ja) * 2005-06-24 2009-01-22 塩野義製薬株式会社 含窒素複素環誘導体
WO2007026950A1 (en) 2005-09-01 2007-03-08 Astellas Pharma Inc. Pyridazinone derivatives used for the treatment of pain
US7968572B2 (en) * 2005-10-03 2011-06-28 Ono Pharmaceuticals Co., Ltd. Nitrogen-containing heterocyclic compound and pharmaceutical application thereof
KR101352973B1 (ko) 2005-10-26 2014-01-22 삼성에스디아이 주식회사 연료전지용 탈황흡착제 및 이를 이용한 탈황방법
AU2007225273A1 (en) * 2006-03-10 2007-09-20 Neurogen Corporation Piperazinyl oxoalkyl tetrahydroisoquinolines and related analogues
JP5182088B2 (ja) * 2006-04-19 2013-04-10 アステラス製薬株式会社 アゾールカルボキサミド誘導体
WO2007139150A1 (ja) * 2006-05-30 2007-12-06 The University Of Tokushima TNFα阻害物質を含有してなる抗インフルエンザウイルス剤
WO2008039882A1 (en) 2006-09-30 2008-04-03 Sanofi-Aventis U.S. Llc A combination of niacin and a prostaglandin d2 receptor antagonist
TW200906825A (en) 2007-05-30 2009-02-16 Scripps Research Inst Inhibitors of protein kinases
US20090054434A1 (en) * 2007-08-23 2009-02-26 Amgen Inc. Isoquinolone derivatives as phosphodiesterase 10 inhibitors
JPWO2009028543A1 (ja) 2007-08-30 2010-12-02 武田薬品工業株式会社 置換ピラゾール誘導体
BRPI0914772A2 (pt) * 2008-06-25 2015-10-20 Envivo Pharmaceuticals Inc compostos heterocíclicos 1,2-dissubstituídos
AP2011005824A0 (en) * 2009-01-26 2011-08-31 Intermune Inc Methods for treating acute myocardial infarctions and associated disorders.
GB0919380D0 (en) * 2009-11-04 2009-12-23 Almac Discovery Ltd Pharmaceutical compouds
ES2539170T3 (es) * 2010-01-12 2015-06-26 Ab Science Inhibidores de quinasas de oxazol
WO2012020786A1 (ja) 2010-08-11 2012-02-16 日本新薬株式会社 医薬組成物
WO2012101654A2 (en) 2011-01-25 2012-08-02 Sphaera Pharma Pvt. Ltd Novel triazine compounds
JP2014122161A (ja) * 2011-03-31 2014-07-03 Astellas Pharma Inc ピラゾール化合物
US8809372B2 (en) * 2011-09-30 2014-08-19 Asana Biosciences, Llc Pyridine derivatives
CN104470918A (zh) 2012-05-30 2015-03-25 日本新药株式会社 芳香族杂环衍生物及医药
AU2012382373A1 (en) 2012-06-12 2014-12-11 Abbvie Inc. Pyridinone and pyridazinone derivatives
AR092742A1 (es) * 2012-10-02 2015-04-29 Intermune Inc Piridinonas antifibroticas
JP2016507496A (ja) * 2012-12-21 2016-03-10 ゼニス・エピジェネティクス・コーポレイションZenith Epigenetics Corp. ブロモドメイン阻害剤としての新規複素環式化合物
BR112015022643A2 (pt) 2013-03-12 2017-07-18 Abbvie Inc inibidores diidro-pirrolpiridinona
US9670221B2 (en) 2013-03-14 2017-06-06 Glaxosmithkline Intellectual Property (No. 2) Limited Furopyridines as bromodomain inhibitors
JPWO2014157569A1 (ja) * 2013-03-28 2017-02-16 武田薬品工業株式会社 複素環化合物
JP6523251B2 (ja) 2013-05-01 2019-05-29 エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft C−結合ヘテロシクロアルキル置換ピリミジン類及びそれらの用途
SG10201804471PA (en) 2013-10-18 2018-07-30 Celgene Quanticel Research Inc Bromodomain inhibitors
HUE041546T2 (hu) 2014-01-09 2019-05-28 Orion Corp Biciklusos heterociklusos származékvegyületek mint bromo doméninhibitorok
MX382781B (es) 2014-04-02 2025-03-13 Intermune Inc Piridinonas anti-fibroticas.
US10064869B2 (en) 2014-06-04 2018-09-04 Thomas Helledays Stiftelse For Medicinsk Forskning MTH1 inhibitors for treatment of inflammatory and autoimmune conditions
CN106687445A (zh) * 2014-09-17 2017-05-17 维颂公司 作为丝氨酸蛋白酶抑制剂的吡唑基取代的吡啶酮化合物
WO2016047678A1 (ja) * 2014-09-25 2016-03-31 武田薬品工業株式会社 複素環化合物
GB201504689D0 (en) * 2015-03-19 2015-05-06 Glaxosmithkline Ip Dev Ltd Chemical compounds
AR104259A1 (es) * 2015-04-15 2017-07-05 Celgene Quanticel Res Inc Inhibidores de bromodominio
CN108024971A (zh) * 2015-07-15 2018-05-11 奥列基因发现技术有限公司 作为irak-4抑制剂的取代的氮杂化合物
JP2018524372A (ja) 2015-07-15 2018-08-30 アウリジーン ディスカバリー テクノロジーズ リミテッド Irak−4阻害剤としてのインダゾール及びアザインダゾール化合物
US10201531B2 (en) * 2015-08-12 2019-02-12 Mochida Pharmaceutical Co., Ltd. Indazolyl-oxo-isothiazole compounds
ES2913048T3 (es) * 2015-09-21 2022-05-31 Opna Immuno Oncology Sa Compuestos heterocíclicos y usos de estos
EP3445750A4 (en) 2016-04-18 2019-11-27 Celgene Quanticel Research, Inc. THERAPEUTIC COMPOUNDS
KR102470130B1 (ko) 2016-07-18 2022-11-24 내셔널 인스티튜트 오브 바이올로지칼 사이언시스, 베이징 아폽토시스 억제제
WO2018195155A1 (en) 2017-04-18 2018-10-25 Celgene Quanticel Research, Inc. Therapeutic compounds
AR111479A1 (es) 2017-04-18 2019-07-17 Celgene Quanticel Res Inc Compuestos derivados de piridina y pirazol

Similar Documents

Publication Publication Date Title
JP2020516672A5 (https=)
JP2019519484A5 (https=)
RU2481333C2 (ru) Производные 1,1,1-трифтор-2-гидрокси-3-фенилпропана
JP2016512259A5 (https=)
JP2022531801A5 (https=)
JP2018118992A5 (https=)
RU2012146246A (ru) Антибактериальные производные изохинолин-3-илмочевины
ME02437B (me) Disupstituirani oktahidropirolo[3,4-c]piroli kao modulatori oreksin receptora
JP2014531465A5 (https=)
JP2014528446A5 (https=)
RU2008141509A (ru) Mglur5 модуляторы 1
JP2019530667A5 (https=)
JP2020522490A5 (https=)
HRP20210431T1 (hr) Pripravci tetrahidrokinolina kao inhibitori bet bromodomene
JP2011503166A5 (https=)
HRP20220096T1 (hr) Inhibitori lizin specifične demetilaze-1
JP2024521618A5 (https=)
HRP20201746T1 (hr) Aromatski derivati sulfonamida
RU2017134901A (ru) Соединения 1-циано-пирролидинов в качестве ингибиторов USP30
JP2007508346A5 (https=)
JP2008542279A5 (https=)
JP2007514690A5 (https=)
HRP20211678T1 (hr) N-supstituirani derivati indola kao modulatori receptora pge2
JP2007510689A5 (https=)
RU2015137615A (ru) Замещенные пиридиновые и пиразиновые соединения в качестве ингибиторов pde4